FilingReader Intelligence

Haisco Pharmaceutical gets approval for autoimmune drug trial

August 7, 2025 at 05:17 PM UTCBy FilingReader AI

Haisco Pharmaceutical Group obtained clinical trial approval from the National Medical Products Administration for HSK47388 tablets, an oral drug for treating autoimmune diseases.

The Class 1 chemical drug showed effective inhibition of inflammatory reactions in preclinical rat studies with good tolerability and wide safety margins.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Haisco Pharmaceutical Group publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →